Skip to main content

Agile Therapeutics Inc

AGRXDelisted Jun 3, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001261249

Agile Therapeutics Inc was delisted on Jun 3, 2024; its insiders filed their last Form 4 on Aug 26, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $496.2K in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Agile Therapeutics Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−5 vs. Q4 2021
Shares held
40.6M
+3.08M (+8.2%) vs. Q4 2021
Total value
$4.04M
−$14.3M (−77.9%) vs. Q4 2021
New holders
5
13 more added
Sold out
10
10 more reduced

3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 39 institutions
Q1 2021: 78 institutionsQ2 2021: 71 institutionsQ3 2021: 54 institutionsQ4 2021: 47 institutionsQ1 2022: 39 institutionsQ2 2022: 21 institutionsQ3 2022: 28 institutionsQ4 2022: 27 institutionsQ1 2023: 23 institutionsQ2 2023: 16 institutionsQ3 2023: 17 institutionsQ4 2023: 21 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $4.04M
Q1 2021: $79.6MQ2 2021: $45.7MQ3 2021: $30.5MQ4 2021: $18.4MQ1 2022: $4.04MQ2 2022: $1.28MQ3 2022: $683.0KQ4 2022: $371.5KQ1 2023: $337.2KQ2 2023: $425.8KQ3 2023: $355.2KQ4 2023: $496.2KQ1 2024: $596Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding AGRX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$596
Q4 202321$496.2K
Q3 202317$355.2K
Q2 202316$425.8K
Q1 202323$337.2K
Q4 202227$371.5K
Q3 202228$683.0K
Q2 202221$1.28M
Q1 202239$4.04M
Q4 202147$18.4M
Q3 202154$30.5M
Q2 202171$45.7M
Q1 202178$79.6M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Agile Therapeutics Inc; share changes are against Q4 2021.

Institutions holding AGRX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC4,547,100$953.0K0.03%+4,547,100New
Vanguard Group Inc3,877,347$812.0K0.00%−617,357−13.7%Reduced
Investor AB3,510,189$737.0K0.02%00.0%Unchanged
D. E. Shaw & Co., Inc.2,197,334$460.0K0.00%+36,328+1.7%Added
BlackRock Inc.1,523,758$319.0K0.00%+16,104+1.1%Added
Millennium Management LLC841,118$176.0K0.00%−97,443−10.4%Reduced
Geode Capital Management, LLC757,888$158.0K0.00%+56,137+8.0%Added
Renaissance Technologies LLC621,200$130.0K0.00%+458,300+281.3%Added
State Street Corp290,345$61.0K0.00%00.0%Unchanged
First Citizens Bank & Trust Co200,000$42.0K0.00%+200,000New
Northern Trust Corp144,816$30.0K0.00%00.0%Unchanged
Grimes & Company, Inc.111,819$23.0K0.00%+27,441+32.5%Added
Parsec Financial Management, Inc.81,000$17.0K0.00%+70,000+636.4%Added
Advisor Group Holdings, Inc.72,950$15.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP68,412$14.0K0.00%−33,384−32.8%Reduced
UBS Group AG56,034$12.0K0.00%+51,400+1,109.2%Added
Morgan Stanley51,812$10.0K0.00%−28,432−35.4%Reduced
Founders Capital Management20,000$10.0K0.01%00.0%Unchanged
Bank of New York Mellon Corp40,667$9.00K0.00%00.0%Unchanged
Group One Trading, L.P.41,277$9.00K0.00%+10,000+32.0%Added
HBK Sorce Advisory LLC35,000$7.00K0.00%00.0%Unchanged
Citadel Advisors LLC26,747$5.00K0.00%−144,231−84.4%Reduced
Citigroup Inc23,580$5.00K0.00%+16,148+217.3%Added
LPL Financial LLC20,244$4.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)19,670$4.00K0.00%+1,380+7.5%Added
Janney Montgomery Scott LLC20,000$4.00K0.00%+10,000+100.0%Added
Two Sigma Securities, LLC18,526$4.00K0.00%+18,526New
Kalos Management, Inc.16,750$3.00K0.00%+16,750New
HRT Financial LP12,704$2.00K0.00%−916−6.7%Reduced
Creative Planning10,200$2.00K0.00%+200+2.0%Added
CWM, LLC5,000$1.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA1,807$3790.00%−43−2.3%Reduced
Royal Bank of Canada1,982$00.00%−9,045−82.0%Reduced
Simplex Trading, LLC265$00.00%−11,289−97.7%Reduced
Aquatic Capital Management LLC2,100$00.00%−1,900−47.5%Reduced
Wells Fargo & Company2,605$00.00%+10+0.4%Added
JPMorgan Chase & Co110$00.00%00.0%Unchanged
Bank of America Corp59$00.00%+59New
Perceptive Advisors LLC21,294,485––00.0%Unchanged
Gsa Capital Partners LLP0$00.00%−733,685−100.0%Sold out
Needham Investment Management LLC0$00.00%−350,000−100.0%Sold out
Virtu Financial LLC0$00.00%−237,642−100.0%Sold out
Jane Street Group, LLC0$00.00%−75,454−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−42,200−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−24,153−100.0%Sold out
Advisory Services Network, LLC0$00.00%−21,000−100.0%Sold out
Victory Capital Management Inc0$00.00%−14,481−100.0%Sold out
Centric Wealth Management0$00.00%−10,000−100.0%Sold out
Captrust Financial Advisors0$00.00%−3,500−100.0%Sold out
First Midwest Bank Trust Division––––Not filed
Reilly Financial Advisors, LLC––––Not filed
NEXT Financial Group, Inc––––Not filed